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Abstract
Background
Diabetes mellitus is a non-communicable disease with a rising prevalence worldwide. Most of the increase in prevalence is 
projected to be in the developing countries. As it is recognised that the onset of the disease and its complications predate 
the symptoms, it is expedient that screening procedures are undertaken to diagnose the disease in the individual as early as 
possible to minimise the risk of complications. Diabetes mellitus is a chronic disease necessitating life-long therapy, usually 
with drugs. This creates a life-long financial burden on the family, especially in low socio-economic communities in West Af-
rica, where the majority of the population still lives on less than one dollar a day. This affects the wellbeing of the entire family, 
hence the need for early detection, prompt and adequate management of the disease and avoidance of its complications.
Methods
The study is an incidental screening to determine the prevalence of diabetes mellitus, its risk factors and the clinical char-
acteristics of diabetics in a Nigerian family practice population. Four hundred and twenty subjects aged 15 years or older 
were recruited by systematic random sampling in a family practice in South West Nigeria over a three-month period. Data 
collected include the subjects’ socio-demographic data, family history of diabetes mellitus and hypertension, and history of 
tobacco and alcohol use. The subjects’ weight and height were measured and their body mass index (BMI) calculated. Each 
subject was examined for peripheral neuropathy, lens opacity and hypertension. Fasting blood glucose was measured using 
a glucometer and urine was tested for albumin. Those with a fasting blood glucose of greater than 6.1 had a fasting blood 
glucose determination by the standard spectrophotometric method. 
 Results
Ten (2.38%) subjects were known diabetics, while 57 (13.6%) were known hypertensives. Ten (2.38%) new diabetics were 
identified, and 7.5% of the females compared to 5.8% of the males were diabetic. Alcohol intake, obesity, age above 44 
years and a positive parental history of diabetes were the significant risk factors (p < 0.01) for diabetes in the study. Protein-
uria and peripheral neuropathy were the significant complications (p < 0.01).
Conclusions
It is concluded that diabetes is a common problem in our practice, with a prevalence of 4.76%, half of which was previ-
ously undiagnosed. Alcohol intake, obesity, positive parental history and age over 44 years were the identified risk factors. 
Peripheral neuropathy, proteinuria and high blood pressure were the identified complications. It is recommended that 
routine screening of people at high risk of diabetes mellitus in family practice be commenced. The glucometer, a relatively 
cheap item of equipment in the practice, is a highly useful, sensitive and specific tool for this purpose.
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Introduction
The prevalence of diabetes mellitus 
is rising worldwide in both developed 
and developing countries.1 Its world-
wide prevalence is about 2%, and the 
prevalence in Nigeria is 2.2%, which 
means that about 2.6 million Nigerians 
are diabetic.2 This means that about 
2.6 million Nigerians are diabetic. It is 
known that 50% of the affected indi-
viduals (about 1.3 million Nigerians) do 
not even know that they have the dis-
ease.3,4 Complications of diabetes mel-
litus have been found to set in long be-
fore clinical manifestation of the dis-
ease.3,4 The onset of complications of di-
abetes mellitus can be reduced if the di-
agnosis is made early and appropriate 
treatment is commenced promptly. Dia-
betes mellitus has a serious impact on 
those affected and their families, hence 
the need for early detection and prompt 
and adequate management. Early de-
tection can be enhanced by screening 
people for the disease on an inciden-
tal basis when consulting for other rea-
sons. General practice provides an ex-
cellent opportunity for this, as most peo-
ple consult their GPs for various reasons 
at least once annually. Furthermore, the 
glucometer has been found to have a 
precision similar to that of routine labo-
ratory systems.5 In addition, an estima-
tion of fasting blood glucose alone has 
been found to be adequate for diabe-
tes screening.4,6,7,8 It was found to have 
a comparable yield to Oral Glucose Tol-
erance Test OGTT in Ghanaians.6 Using 
a simple glucometer, the family physi-
cian can easily undertake the screening 
of at-risk people in his/her practice pop-
ulation with minimal inconvenience.
The family physician is ideally posi-
tioned to screen for type 2 diabetes mel-
litus in view of its familial tendency and 
particularly as the family assumes re-
sponsibility in health interaction as part 
of its normal functioning. 
Objectives
The objectives of the study were to de-
termine the prevalence of diabetes mel-
litus and identify its risk factors in a gen-
eral practice population 
Methods
This is a descriptive, cross-section-
al, practice-based study of patients 15 
years and older attending the Gener-
al Practice Department of the Obafe-
mi Awolowo University Teaching Hos-
pitals Complex (OAUTHC) in Ile-Ife, 
South Western Nigeria. The study was 
conducted over the three-month period 
from January to March 2004.
Of 3 250 new attendees for reasons 
ranging from a medical check-up to ill-
nesses during the study period, a total 
of 420 patients who consented to par-
ticipate in the study by providing fast-
ing blood samples were selected by 
systematic random sampling. Severely 
ill patients, those who had eaten with-
in 12 hours prior to the evaluation, pa-
tients who were dehydrated or on L-
dopa-containing drugs were excluded 
from the study.
Data were collected with the aid 
of a structured interviewer-adminis-
tered questionnaire, an AccuChek Ac-
tive® blood glucose monitor (Serial no: 
GG03110346; Art. no: 2248891001), 
Albustix® strips for proteinuria, a bath-
room weighing scale, a standiome-
ter and an Accosson® brand mercury 
sphygmomanometer. The information 
collected included the age, sex, occu-
pation and marital status of the subjects. 
The subjects’ smoking and alcohol his-
tory, as well as their past medical and 
family history of diabetes and hyperten-
sion were obtained. Complications of di-
abetes mellitus, such as skin infections, 
foot ulcers, peripheral neuropathy and 
macrovascular disease were looked for 
on physical examination and recorded.
The blood pressure of the subjects 
was measured in the sitting position us-
ing the left arm. The body mass index 
(BMI), kg/m2, was calculated for each 
subject. Subjects were grouped accord-
ing to the WHO classification of obesity.9 
Blood sugar was determined for each 
subject using a fresh capillary fasting 
blood sample by the glucometer meth-
od. Patients whose fasting blood sugar 
level was above 6.1 mmol/l had confir-
matory fasting venous blood samples 






















Figure 1: Past medical history of study respondents
HT = hypertension; DM = diabetes mellitus  
Figure 2: Distribution of fasting hyperglycaemia among respondents
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laboratory blood sugar determination. 
Standard precautions and procedures 
were followed for all measurements. 
All data collected were fed into the 
computer and analysed using the Epi 
Info 2002 Revision 2 software.10 Data 
were presented using relative frequen-
cies, mean, median and mode. The 
prevalence of impaired fasting glucose 
and diabetes mellitus was determined. 
The prevalence of complications in hy-
perglycaemic and euglycaemic sub-
jects was compared using χ2 statistics. 
The relative risk and odds ratio were de-
termined for each risk factor for diabe-
tes and complication. The level of signif-
icance was set at p < 0.05. Ethical ap-
proval was obtained from the OAUTHC 
ethical committee.
Results
A total of 420 subjects were screened 
for diabetes mellitus. The majority of the 
subjects were 45 years or older (56.7%), 
females (62.9%) and married (63.3%). 
Only 4% and 1% of the screened sub-
jects had positive parental and sibling 
history of DM respectively, compared 
with 6.9% and 3.1% of positive paren-
tal and sibling history of hypertension re-
spectively. Figure 1 shows the medical 
history of the study subjects.
By using the glucometer, it was found 
that nine (2.9%) subjects had impaired 
fasting glycaemia, while 20 (4%) were 
in the diabetic range. The others were 
euglycaemic. Most (19, 79.2%) of the 
subjects with hyperglycaemia were fe-
males. Figure 2 shows the distribution 
of subjects with fasting hyperglycaemia. 
Four subjects whose glucometer read-
ings were higher than 6.1 mmol/l did 
not come back with a laboratory result, 
while one had a laboratory fasting blood 
glucose of 5.3 mmol/l, giving a positive 
predictive index of 96% (24/25) for the 
glucometer. Of the 420 subjects, a total 
of 188 (44.8%) were either overweight 
(110, 26.2%) or obese (78, 18.6%). Sev-
enteen (58.6%) of the hyperglycaemic 
subjects were overweight (7, 41%) or 
obese (10, 59%).
Table I shows that fasting hyper-
glycaemia was commoner in people 
45 years and older (22, 9.2%) than 
among those 44 years or younger (2, 
1.1%). More females (19, 7.2%) were 
hyperglycaemic than males (5, 3.2%]) 
Age, sex, alcohol intake, obesity and 
having a diabetic parent were signifi-
cantly associated with the presence of 
diabetes mellitus, as shown in Table I (p 
< 0.05). This table also shows that high 
diastolic blood pressure (p = 0.03) was 
a significant risk factor for diabetes, but 












Odds ratio = 0.11
[95% CI 0.01 – 0.47]








Odds ratio = 0.44
[95% CI 0.13 – 1.25]








Odds ratio = 2.18
[95% CI 0.67 – 6.06]








Odds ratio = 26.61
[95% CI 8.42 – 109.41] 








Odds ratio = 2.64
[95%CI 1.03 – 7.28]








Odds ratio = 5.83
[95% CI 1.26 – 21.09]








Odds ratio = 0.00
[95% CI 0.00 – -25.58]
















Odds ratio = 1.22
[95% CI 0.49 – 3.00]
X2 = 0.21, p = 0.65
Odds ratio = 2.41
[95% CI 0.98 – 6.02]
X2 = 4.48, p = 0.03
Table I: Risk factors associated with hyperglycaemia in the study
































































Table II: Characteristics of the hyperglycaemic subjects by type of hyperglycaemic state*
*29 identified with the glucometer 
high systolic blood pressure (p = 0.65) 
was not.
Table II shows that all 10 subjects 
with unrecognised diabetes were 45 
years or older, and of these nine (90%) 
were obese and six (60%) were female. 
Eight (88.9%) of the nine with unrecog-
nised impaired fasting glycaemia (IFG) 
were obese and all were females 45 
years or older. 
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Table III shows that fasting hypergly-
caemia, female gender and high blood 
pressure were the significant character-
istics found among those with a positive 
parental history of diabetes (p < 0.05).
Table IV shows that peripheral neu-
ropathy and proteinuria are the most 
frequent complications of hyperglyce-
mia observed in this study. Of those with 
unrecognised DM and IFG, five (50%) 
and none had neuropathy and five 
(50%) and five (55.6%) had proteinuria 
respectively.
Discussion
In this study, 20 subjects (4.76%) were 
found to be diabetic. This is higher 
than the Nigerian national prevalence 
of 2.2%2 and the worldwide prevalence 
of 2%.11 In 1997, Owoaje et al. found 
a prevalence of 2.8% in Ibadan, Nige-
ria.12 Olatunbosun and Bella, however, 
reported a prevalence of 0.8% in the 
same community in 1998.13 The marked 
difference in the proportion of diabetics 
in this study can partly be explained by 
the fact that it is a practice-based study 
in contrast to the others, which were 
community based. There is, however, 
a recognised trend of increasing prev-
alence worldwide.11,14 The WHO has cit-
ed urbanisation as a recognised factor 
in the increasing prevalence of diabetes 
worldwide.15 The greatest increase in the 
prevalence of type 2 diabetes is expect-
ed from developing countries as a di-
rect result of increasing urbanisation.15,16 
A review of studies on the prevalence 
of diabetes in adults in Africa by Unwin 
et al. demonstrated a rising prevalence 
across the continent.15 The prevalence 
of type 2 diabetes of 6.3% in Ghana,17 
and 8% in Cape Town and Australia, are 
much higher than in the present study.1,18 
Ghana and Nigeria, both in West Africa, 
have similar socioeconomic environ-
ments, while South Africa and Australia 
are socioeconomically more developed. 
 In this study, the positive predic-
tive index of the glucometer was 96%. 
Bitzen and Schersten found no differ-
ence in specificity and predictability 
compared with the standard laboratory 
method.19 Previous studies have dem-
onstrated the comparability of the glu-
cometer and standard laboratory meth-
ods in blood glucose estimation.6,20 Ajala 
et al. compared three brands of glucom-
eter with the standard laboratory method 
and got a correlation coefficient of 0.990 
for Accutrend Alpha®, manufactured by 
Roche Diagnostics, which manufac-
tured the AccuChek Active® glucometer 
used in this study.6 Murphy et al. got a 
correlation coefficient of 0.85 and a sen-
sitivity of 92% with the AccuChek II glu-
Table III: Characteristics of the subjects with positive parental history of diabetes
Positive parental 
history n = 17
Negative parental 










Odds ratio = 5.83
[95% CI = 1.26 – 21.09]








Odds ratio = 4.52
[95% CI = 1.03 – 41.16]








Odds ratio = 0.38
[95% CI = 0.01– 2.51]








Odds ratio = 1.27
[95% CI = 0.29 – 4.24]








Odds ratio = 3.41
[95% CI = 0.99 – 10.52]
Χ2 = 6.03, p = 0.02







Odds ratio = 1.43
[95% CI = 0.49 – 4.15] 
Χ2 = 0.51, p = 0.47
Table IV: Relative prevalence of complications of hyperglycaemia in subjects by glycaemic status
Complication
Hyperglycaemia 
(FBS > 6.1 mmol/l)
n = 24
Normoglycaemia 
(FBS ≤ 6.1 mmol/l)


























X2 = 2.75, p =0.21
High blood pressure
Yes
No 9 [37.5%]15 [62.5%]
105 [26.8%]
287 [73.2%]
X2 = 1.30, p = 0.25
cometer in 15 Alaskan villages.20
This study identified ten subjects 
(2.4%) with previously undetected dia-
betes mellitus and a further nine (2.1%) 
who had unrecognised impaired fasting 
glycaemia. This agrees with the findings 
of previous studies.11,21,22. Olatunbosun 
et al., studying 998 civil servants in 
Ibadan, found a prevalence of 0.8% and 
0.5% for diabetes mellitus and previ-
ously undiagnosed diabetes mellitus 
respectively.23 The finding of 2.4% as 
the proportion in the study population 
with unrecognised diabetes mellitus in 
our study is highly comparable to the 
findings of Elbagir et al.,21 who found 
2.2% in Sudan, and Greaves et al.,22 
who found between 2.6% and 4.7% 
among groups of patients with different 
risk factors in a UK family practice set-
ting. In the United Kingdom Prospective 
Diabetes Study UKPDS, Edelman et al. 
found a 4.5% prevalence of unrecog-
nised diabetes mellitus in an out-patient 
clinic population in the United States.24 
In our study, 50% of the diabetics had 
not been diagnosed previously, which 
agrees with the projection of King et 
al.,11,25  Mbanya et al.26 and Amoah et 
al.,17 who report that between 30 and 
70% of diabetics are previously undiag-
nosed and asymptomatic.
Alcohol was found to be positively 
associated with diabetes mellitus in this 
study. Most (96.5%) of the subjects who 
used alcohol in this study took less than 
five units of alcohol daily. An association 
between alcohol and diabetes has been 
documented by various authors.27,28 
There is a non-linear relationship be-
tween alcohol intake and the risk of type 
2 diabetes.28 Wei et al.29 and Nakanishi 
et al.30 observed that alcohol excess or 
abstinence increases the risk of devel-
oping diabetes. Levitt et al., on the other 
hand, reported that alcohol intake was 
not a significant risk factor for diabetes 
mellitus in South Africa.18 
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Seventeen of the 29 hyperglycaemic 
subjects (75.9%) were obese. Several 
researchers have demonstrated a sig-
nificantly higher prevalence of type 2 
diabetes among the obese compared 
with the non-obese.13,18,23,31,32 Olatun-
bosun et al. observed that high body 
mass index is associated with increased 
blood glucose in their study in Ibadan, 
Nigeria.23 Owoaje et al., in another study 
in Ibadan, reported a 1.5-fold increase 
in the risk of developing elevated fasting 
blood glucose in the obese.13 Obesity 
is known to be a consistent risk factor 
for type 2 diabetes in people of African 
origin living in Cameroon, Jamaica and 
Britain.31 Hillier et al. observed that obe-
sity was a continuous risk rather than 
a threshold risk for diabetes onset.32 In 
the present study, nearly all subjects 
(89.5%) with previously unrecognised 
fasting hyperglycaemia compared with 
50% of known diabetics were obese. 
Edelman et al. found obesity and hyper-
tension to be significant risk factors for 
unrecognised diabetes in an outpatient 
setting in Durham, USA.24
Fasting hyperglycaemia is more 
common among females than males in 
this study (female:male = 1.7:1). The 
Nigerian National Non-communicable 
Disease Survey and other studies have 
made similar observations.2,33 This, how-
ever, contrasts with the report of Amoah 
et al., who observed a slightly higher 
preponderance among males than fe-
males.17 Our finding may be explained 
by the finding of a significantly higher 
proportion of obese females than males 
in this study.
There is strong evidence in the litera-
ture that type 2 diabetes is commoner 
among first-degree relatives of affected 
individuals.23,24,33 This has been corrobo-
rated in this study by a strong positive 
association between fasting hypergly-
caemia and parental history of type 2 
diabetes (Odds ratio 5.8, CI 1.3-21.1). 
However, the present study could not 
demonstrate an association with a posi-
tive sibling history of type 2 diabetes.
Complications associated with dia-
betes mellitus in this study were periph-
eral neuropathy, proteinuria and high 
blood pressure (p < 0.05). Reenders et 
al. reported that 68% and 57% of their 
subjects with NIDDM in GP settings in 
the Netherlands had neuropathy and 
nephropathy respectively. 34 Similar 
findings have been reported by other 
workers.35,36,37 Harris et al. observed 
that complications may develop before 
a clinical diagnosis is made.38 The find-
ings of this study also agree with this 
observation.
High diastolic blood pressure was sig-
nificantly and positively associated with 
fasting hyperglycaemia in this study (p 
= 0.03). In an out-patient clinic popula-
tion akin to the present study population, 
Edelman et al. found hypertension to be 
associated with unrecognised diabetes 
(p = 0.004).24 In agreement with the 
finding of the current study, Hillier et al. 
observed that diastolic hypertension but 
not systolic hypertension was associ-
ated with type 2 diabetes mellitus.32 The 
association of fasting hyperglycaemia 
and elevated blood pressure in this 
study is further supported by Agaba et 
al., who reported hypertension in half of 
diabetics in a study in Jos, Nigeria.39
Conclusions
Diabetes mellitus is a common, non-
communicable disease among patients 
presenting at our Family Practice Clinic, 
occurring in 4.8% of new patients, half 
of whom had not been diagnosed pre-
viously. It was more common in the fe-
males, with a male:female ratio of 1:1.7, 
and in people older than 44 years, with 
all those with unrecognised diabetes 
mellitus being above this age.
Obesity, having a diabetic parent 
and alcohol intake were associated with 
diabetes mellitus in this study. Protein-
uria and peripheral neuropathy develop 
in the sub-clinical phase of the disease, 
being present in 41.7% and 58.3% of 
the subjects with fasting hyperglycae-
mia respectively. 
The glucometer was found to be a 
reliable tool for screening patients for 
diabetes, with a positive predictive in-
dex of 96% in this study.
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